Cargando…

Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious threat to global public health. In an effort to develop novel anti-coronavirus therapeutics and achieve prophylactics, we used gene set enrichment analysis (GSEA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chia-Yin, Nguyen, Anh Thuc, Doan, Ly Hien, Chu, Li-Wei, Chang, Chih-Hung, Liu, Hui-Kang, Lee, I-Lin, Wang, Teng-Hsu, Lai, Jin-Mei, Tsao, Shih-Ming, Liao, Hsiu-Jung, Ping, Yueh-Hsin, Huang, Chi-Ying F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054482/ https://www.ncbi.nlm.nih.gov/pubmed/36992350 http://dx.doi.org/10.3390/v15030641

Ejemplares similares

Astragalus Polysaccharide Injection (PG2) Normalizes the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Lung Cancer Receiving Immunotherapy
por: Tsao, Shih Ming, et al.
Publicado: (2021)

Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade
por: Huang, Wen-Chien, et al.
Publicado: (2019)

Astragalus polysaccharides (PG2) Enhances the M1 Polarization of Macrophages, Functional Maturation of Dendritic Cells, and T Cell-Mediated Anticancer Immune Responses in Patients with Lung Cancer
por: Bamodu, Oluwaseun Adebayo, et al.
Publicado: (2019)

Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction
por: Guimond, Scott E., et al.
Publicado: (2022)

A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
por: Tsegay, Kaleb B., et al.
Publicado: (2021)

Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study
por: Wang, Cheng-Hsu, et al.
Publicado: (2019)

Molecular Weight and Monosaccharide Composition of Astragalus Polysaccharides
por: Xu, Du-Juan, et al.
Publicado: (2008)

A Review of the Pharmacological Action of Astragalus Polysaccharide
por: Zheng, Yijun, et al.
Publicado: (2020)

The influence of astragalus polysaccharide and β-elemene on LX-2 cell growth, apoptosis and activation
por: Zheng, Jin, et al.
Publicado: (2014)

Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro
por: Yeh, Yuan-Chieh, et al.
Publicado: (2022)

Astragalus polysaccharide ameliorates H(2)O(2)-induced human umbilical vein endothelial cell injury
por: Han, Ronghui, et al.
Publicado: (2017)

Astragalus polysaccharides attenuate PCV2 infection by inhibiting endoplasmic reticulum stress in vivo and in vitro
por: Xue, Hongxia, et al.
Publicado: (2017)

Repair Effects of Astragalus Polysaccharides with Different Molecular Weights on Oxidatively Damaged HK-2 Cells
por: Han, Jin, et al.
Publicado: (2019)

Astragalus polysaccharide strengthens the inflammatory and immune responses of Brucella suis S2-infected mice and macrophages
por: Shi, Qiwen, et al.
Publicado: (2019)

Interference of Quercetin on Astragalus Polysaccharide-Induced Macrophage Activation
por: Li, Zhi-Peng, et al.
Publicado: (2018)

Effects of Apigenin and Astragalus Polysaccharide on the Cryopreservation of Bull Semen
por: Wang, Hongtao, et al.
Publicado: (2021)

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19
por: BR, Bharath, et al.
Publicado: (2020)

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface
por: Pirolli, Davide, et al.
Publicado: (2023)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Astragalus polysaccharides inhibit oxidation in high glucose-challenged or SOD2-silenced H9C2 cells
por: Chen, Wei, et al.
Publicado: (2018)

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
por: Ahmad, Iqrar, et al.
Publicado: (2021)

Sulfated polysaccharides act as baits to interfere with the binding of the spike protein (SARS-CoV-2) to the ACE2 receptor and can be administered through food
por: Barbosa, Jhonatas Rodrigues, et al.
Publicado: (2023)

Genotoxicity Study of Polysaccharide Fraction from Astragalus membranaceus's Aerial Parts
por: Park, Yeong-Chul, et al.
Publicado: (2014)

Angelica sinensis Polysaccharide and Astragalus membranaceus Polysaccharide Accelerate Liver Regeneration by Enhanced Glycolysis via Activation of JAK2/STAT3/HK2 Pathway
por: Wen, Xu-Dong, et al.
Publicado: (2022)

Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2+/-) knockout mice
por: Ju, J., et al.
Publicado: (2017)

Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine
por: Zhao, Danping, et al.
Publicado: (2023)

A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)
por: Coghi, Paolo, et al.
Publicado: (2021)

Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels
por: Yu, Zugong, et al.
Publicado: (2017)

Wound healing effect of an Astragalus membranaceus polysaccharide and its mechanism
por: Zhao, Bingjiang, et al.
Publicado: (2017)

Effects of Astragalus Polysaccharides Nanoparticles on Cerebral Thrombosis in SD Rats
por: Sun, Qian, et al.
Publicado: (2020)

Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
por: Xu, Qian, et al.
Publicado: (2023)

Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface
por: Pirolli, Davide, et al.
Publicado: (2023)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora
por: Liu, Jiayue, et al.
Publicado: (2022)

A case series report on successful management of patients with COVID-19-associated lymphopenia and potential application of PG2
por: Wang, Wei-Yao, et al.
Publicado: (2022)

Astragalus polysaccharide enhances immunity and inhibits H9N2 avian influenza virus in vitro and in vivo
por: Kallon, Sanpha, et al.
Publicado: (2013)

Comparison of the adhesion and endocytosis of calcium oxalate dihydrate to HK-2 cells before and after repair by Astragalus polysaccharide
por: Han, Jin, et al.
Publicado: (2019)

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
por: Luan, Junwen, et al.
Publicado: (2020)

Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
por: Lee, Myeongsang, et al.
Publicado: (2023)

Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
por: Alexpandi, Rajaiah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_49n24hp2durgvsrgh32e7b8b67